5
Views
11
CrossRef citations to date
0
Altmetric
SHORT COMMUNICATIONS

Efficacy of ivermectin treatment of Loa loa filariasis patients without microfilaraemias

, , , , , & show all
Pages 93-94 | Received 15 Jun 1993, Accepted 29 Sep 1993, Published online: 15 Nov 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

M. Boussinesq. (2006) Loiasis. Annals of Tropical Medicine & Parasitology 100:8, pages 715-731.
Read now
M. Boussinesq & J. Gardon. (1997) Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection. Annals of Tropical Medicine & Parasitology 91:6, pages 573-589.
Read now

Articles from other publishers (9)

Michael Ramharter, Joanna Butler, Ghyslain Mombo-Ngoma, Tamara Nordmann, Saskia Dede Davi & Rella Zoleko Manego. (2024) The African eye worm: current understanding of the epidemiology, clinical disease, and treatment of loiasis. The Lancet Infectious Diseases 24:3, pages e165-e178.
Crossref
Areeba Rahman, Abdulaziz S. Alouffi, Mohammad Husain & Abdur Rub. 2023. Chemistry and Biological Activities of Ivermectin. Chemistry and Biological Activities of Ivermectin 69 92 .
J.H.F. Remme, B. Boatin & M. Boussinesq. 2023. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Laurentine Sumo, Ngum Helen Ntonifor, Aza'ah René Afor, Jean Bopda, Rolph Bamou Heumou, Gabriella S. Ondoua Nganjou & Hugues C. Nana Djeunga. (2022) Loiasis is endemic in the Ndikinimeki Health District (Centre Region, Cameroon) but does not represent a hindrance to onchocerciasis elimination. Acta Tropica 225, pages 106218.
Crossref
Hugues Nana-Djeunga, Cédric Lenou-Nanga, Cyrille Donfo-Azafack, Linda Djune-Yemeli, Floribert Fossuo-Thotchum, André Domche, Arsel Litchou-Tchuinang, Jean Bopda, Stève Mbickmen-Tchana, Thérèse Nkoa, Véronique Penlap, Francine Ntoumi & Joseph Kamgno. (2020) Collateral Impact of Community-Directed Treatment with Ivermectin (CDTI) for Onchocerciasis on Parasitological Indicators of Loa loa Infection. Pathogens 9:12, pages 1043.
Crossref
Jean-Claude Makenga Bof, Daniel Muteba, Paul Mansiangi, Félicien Ilunga-Ilunga & Yves Coppieters. (2019) Analysis of severe adverse effects following community-based ivermectin treatment in the Democratic Republic of Congo. BMC Pharmacology and Toxicology 20:1.
Crossref
Samuel Wanji, Winston Patrick Chounna Ndongmo, Fanny Fri Fombad, Jonas Arnaud Kengne-Ouafo, Abdel Jelil Njouendou, Yolande Flore Longang Tchounkeu, Benjamin Koudou, Moses Bockarie, Grace Fobi, Jean Baptiste Roungou & Peter A. Enyong. (2018) Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa. PLOS Neglected Tropical Diseases 12:9, pages e0006750.
Crossref
Joseph Kamgno, Hugues Clotaire Nana-Djeunga & Marc Kouam-Kenmogne. 2016. Neglected Tropical Diseases - Sub-Saharan Africa. Neglected Tropical Diseases - Sub-Saharan Africa 135 157 .
Michel Boussinesq. (2012) Loiasis: New Epidemiologic Insights and Proposed Treatment Strategy. Journal of Travel Medicine 19:3, pages 140-143.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.